American Thrombosis and Hemostasis Network ATHNdataset Registry

Clinical Trial Information

Trial Contact: Jones, Jamie, Singh, Sarah H, Torrescano, Tanner, Frankos, Marie

IRB No: 25.079.04

Principal Investigator: Rafique, Amina MD

Phase: N/A

Age Group: CHILDADULTOLDER_ADULT

ClinicalTrials.gov ID: NCT06820515

Objective

to develop a secure, comprehensive registry of real-world clinical data to support standardized comprehensive health information for persons living with blood disorders and public health reporting for the blood disorders community

Share:

Related Clinical Trials

A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination with Rilvegostomig in Participants with High-risk Muscle Invasive Urothelial Carcinoma (TROPION-Urothelial04)
An Interventional Phase III, Open-Label, Randomized Study to Evaluate Efficacy and Safety of PF-08634404 in Combination with Chemotherapy versus Pembrolizumab in Combination with Chemotherapy in Adult Participants with Advanced or Recurrent Mismatch Repair Proficient Endometrial Cancer
Study of a New Device for Severe Asthma (PULSAR)
A Randomized, Open-Label Phase III Study of Azenosertib versus Investigator's Choice of Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression